人脑工程概念强势拉升 三博脑科、翔宇医疗等涨停

Group 1 - The brain-computer interface (BCI) sector is experiencing a significant surge, with companies like Beikang, Sanbo Brain Science, and Xiangyu Medical reaching their daily price limits, driven by Elon Musk's announcement regarding Neuralink's plans for large-scale production of BCI devices by 2026 [1] - Neuralink's new automated surgical approach, which allows electrode wires to penetrate the dura mater without removal, aims to reduce the invasiveness of traditional devices and optimize efficiency and costs through automation [1] - Merge Labs, co-founded by OpenAI's CEO Sam Altman, is spinning off to focus on a new generation of ultrasound-based BCI technology that can interpret brain signals without the need for implanted electrodes [1] Group 2 - According to Open Source Securities, Neuralink's anticipated large-scale production and automated surgical methods, along with Merge's ultrasound technology, signify a transition from clinical validation to commercial scalability for BCIs, moving them from "medical trial tools" to "widely available products" [2] - The BCI industry is poised for high growth driven by technological breakthroughs, policy support, and synergies with robotics, with the global BCI market projected to reach approximately $12.4 billion by 2034, reflecting a CAGR of 17% from 2025 to 2034 [2] - The recent expectations for Neuralink's mass production and technological advancements are expected to benefit related A-share BCI companies [2]